Moderna, Inc.
MRNA
$27.12
$0.903.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.04% | 13.30% | -8,715.38% | 101.02% | -8.85% |
| Total Depreciation and Amortization | 46.15% | -35.00% | 15.38% | 26.83% | 13.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.74% | -28.38% | 51.02% | -10.91% | 22.22% |
| Change in Net Operating Assets | -40.76% | -112.15% | 200.46% | -1,084.25% | -343.33% |
| Cash from Operations | 11.38% | -225.70% | 152.68% | -22.92% | -28.82% |
| Capital Expenditure | 97.44% | 77.59% | -245.70% | 17.03% | 7.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.06% | 5,082.35% | -101.95% | -52.38% | 483.12% |
| Cash from Investing | -22.74% | 235.44% | -174.76% | -56.28% | 1,297.46% |
| Total Debt Issued | -200.00% | 150.00% | -233.33% | 200.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 366.67% | -72.73% | 37.50% | -75.00% | 113.33% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 125.00% | 233.33% | -127.27% | -67.65% | 142.86% |
| Foreign Exchange rate Adjustments | -- | -- | -200.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.86% | -207.45% | 133.85% | -303.67% | 147.72% |